Relay Therapeutics, Inc. Preferred Stock Dividends and Other Adjustments
Relay Therapeutics, Inc. (RLAY) reported Preferred Stock Dividends and Other Adjustments of -$177.79 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-02-24.
Discontinued › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2022-02-24
- Relay Therapeutics, Inc. preferred stock dividends and other adjustments for the quarter ending 2020-12-31 was -$355.58M.
- Relay Therapeutics, Inc. preferred stock dividends and other adjustments for the quarter ending 2020-09-30 was $177.79M.
- Relay Therapeutics, Inc. preferred stock dividends and other adjustments for fiscal 2020 was -$177.79M.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 3 month as first filed | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 9 month as first filed | Preferred Stock Dividends and Other Adjustments 12 month | Preferred Stock Dividends and Other Adjustments 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2020-12-31 | -$355.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$177.79M derived: sum of 2 quarters · filed 2022-02-24 | -$177.79M 10-K · filed 2022-02-24 | $177.79M 10-K · filed 2021-03-25 | |||
| 2020-09-30 | $177.79M 10-Q · filed 2021-11-10 | -$177.79M 10-Q · filed 2020-11-12 | $177.79M 10-Q · filed 2021-11-10 | -$177.79M 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |